Oktenli, Cagatay <br/><br/>
Metformin decreases circulating acylation-stimulating protein levels in polycystic ovary syndrome.  [electronic resource] 

 -  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology  Dec 2007 
 - 710-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0951-3590 
<br/><br/><label>Standard No.: </label>10.1080/09513590701666571  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acylation--drug effects<br/>Adult<br/>Body Mass Index<br/>Case-Control Studies<br/>Complement C3a--drug effects<br/>Female<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>Metformin--pharmacology<br/>Polycystic Ovary Syndrome--drug therapy